- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04586127
Improving Care Coordination for Adolescents and Young Adults With Cancer
Improving Care Coordination for Adolescents and Young Adults With Cancer: Implementing a Bridge Between Needs and Services
Study Overview
Detailed Description
Adolescents and young Adults (AYA) Needs Assessment & Service Bridge (AYA NA-SB) includes a holistic Patient Reported Outcome Measures (PROM) assessing AYAs' physical, psychosocial and practical needs and a collection of referral pathways for connecting AYAs to services and resources based on the needs they report.
To assess the implementation of AYA NA-SB, the study team will pilot AYA NA-SB in the North Carolina Cancer Hospital (NCCH)/ UNC Children's Hospital, with a primary focus on implementation outcomes (i.e., feasibility, acceptability, appropriateness, fidelity). To establish proof-of-concept for AYA NA-SB, the study team will use pilot data to generate preliminary evidence on the extent to which AYA NA-SB addresses AYAs' reported needs.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
North Carolina
-
Chapel Hill, North Carolina, United States, 27514
- North Carolina Cancer Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- AYAs with cancer ages 18 through 39 currently undergoing cancer treatment at the North Carolina Cancer Hospital/ UNC Children's Hospital
Exclusion Criteria:
- Patients who decline to participate in the study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Adolescents and Young Adults Needs Assessment & Service Bridge (AYA NA-SB)
Subjects will complete 2 online surveys over the course of 1 month; each should take about 15 minutes to complete.
|
Questionnaire identifying cancer needs so that providers can connect subjects with services that might address them.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Feasibility of Intervention Measure (FIM) AYA
Time Frame: Week 5
|
Questionnaire measuring the extent to which AYA NA-SB can be successfully used in cancer programs.
Score ranges from 1 to 5 with higher score denoting higher feasibility.
|
Week 5
|
|
Acceptability of Intervention Measure (AIM) AYA
Time Frame: Week 12
|
Questionnaire measuring perception of whether AYA-NA-SB is agreeable, palatable, or satisfactory to users.
Score ranges from 1 to 5 with a higher score denoting higher acceptability.
|
Week 12
|
|
Intervention Appropriateness Measure (IAM) AYA
Time Frame: Week 5
|
Questionnaire measuring perception of AYA-NA-SB's fit, relevance, or compatibility with the context in which it will be used.
Score ranges from 1 to 5 with a higher score denoting higher appropriateness
|
Week 5
|
|
Number of Participants Who Received Services
Time Frame: Week 12
|
Care coordination will be assessed by the proportion of Adolescents and Young Adults (AYAs) who reported needs who received services from across disciplines to address reported needs within one month of needs assessment completion.
|
Week 12
|
|
Needs Met Questionnaire
Time Frame: Week 12
|
Questionnaire assessing, among AYAs who reported needs and reported receiving follow-up care, AYAs' perception of the degree to which their needs were adequately addressed during the study period.
Scores range from 1 to 5 where higher scores denote that needs were met.
|
Week 12
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of AYA Needs
Time Frame: Week 12
|
Average number of needs reported by AYAs.
|
Week 12
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Emily Haines, MD, Wake Forest University Health Sciences
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- IRB00068240
- P30CA012197 (U.S. NIH Grant/Contract)
- P50CA244693 (U.S. NIH Grant/Contract)
- 2T32CA122061 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.